‘Heated Rivalry’ Actor Harrison Browne on Life as a Transgender Athlete

Heated Rivalry actor Harrison Browne on his – Harrison Browne, the Canadian actor and first openly transgender professional hockey player, has turned his personal journey into a powerful narrative. His story, explored in the TV series *Heated Rivalry*, also serves as a platform for discussing the complexities of gender identity in sports. Before stepping into the spotlight, Browne was a quiet figure in the locker room, living a life that many would consider ordinary—until the moment he decided to embrace his true self.

From Locker Room to Spotlight

Long before his public revelation, Browne was known as “Brownie” among teammates. The nickname, he recalls, provided a temporary shield, allowing him to navigate the world of women’s hockey without drawing attention. “Hockey was the one place where I could turn my brain off,” he said, reflecting on how the sport offered a sanctuary. “The one space where my body wasn’t the enemy. All that mattered was how fast my feet moved.”

“I could just say, ‘Hey, I’m the same Brownie — can you use he/him pronouns?’” he remembered. “And my teammates were like, ‘Yes, absolutely.’”

But this acceptance was not universal. While in the locker room, Browne felt a sense of belonging, yet outside, his identity was often erased. “I was living a double life,” he explained. “I was Harrison in the locker room. But when I stepped out in public — my name on the roster wasn’t Harrison. I was announced with she/her pronouns. It became a bigger disconnect.” The emotional weight of this duality shaped his perspective, ultimately leading him to confront his identity publicly.

Breaking Barriers in Professional Hockey

In 2016, Browne made history by coming out as a man while playing for the now-defunct Buffalo Beauts, a professional women’s hockey team. This moment marked his transformation into the first openly transgender athlete in a professional team sport. The significance of this milestone cannot be overstated; it not only paved the way for others but also ignited a global conversation about fairness, biology, and the essence of athletic competition.

Over the past decade, the debate surrounding transgender athletes has intensified. Issues of gender identity in sports have become polarizing, with discussions ranging from hormone therapy to the role of testosterone in performance. Yet, for many athletes like Browne, the core of the issue is not just political—it’s deeply personal. “Transgender kids aren’t the problem in youth sports,” said one parent, echoing the sentiment that the controversy often overshadows the real challenges athletes face.

The Science Behind the Debate

As the discourse evolved, so did the research supporting transgender athletes. By the time Browne began co-authoring *Let Us Play* with his sister, Rachel Browne, a science journalist, the public debate had already reached a fever pitch. “We were seeing this wave of anti-trans legislation really take off,” he noted. Such legislation, he argued, reflects a moral panic—a reaction driven more by emotion than evidence.

“A ferocious reaction to a small group of people doing something perceived as negative has all the signs of a moral panic,” Browne said. “It distracts from broader issues like healthcare, poverty, and human rights.”

Central to the controversy is the idea that hormones, especially testosterone, dictate athletic success. This belief, however, is what Browne calls “reductive and misleading.” “When we focus so solely on one hormone,” he said, “we’re overlooking the real barriers to fairness in sport.”

Training, access to coaching, nutrition, and socioeconomic status are factors that consistently influence athletic performance, he emphasized. “Sports have never been fair,” Browne asserted. “If they were, everyone would be the same height and have the same access to resources, but that’s just not reality.”

Dehumanizing the Athlete

Beyond the statistics, Browne believes the way transgender athletes are framed in the media risks dehumanizing them. “Reducing people to their physiology,” he said, “takes away from the complexity of their lives.” For him, the focus on biological variables often masks the emotional and psychological toll of competing in a space where one’s identity is constantly questioned.

“You’re just talking about their bodies — not their lives,” he added. “That’s why it’s so important to highlight the human element behind every athlete’s story.”

The argument over testosterone’s impact has also sparked a growing body of scientific inquiry. A recent study found that gender-affirming hormone therapy is linked to lower depression rates in transgender adults, challenging the notion that athletic performance is solely a matter of biology. “The single biggest misconception is that testosterone is some kind of permanent performance-enhancing drug,” said Ada Cheung, an endocrinologist contributing to the research. “Once you’ve been exposed to it, the advantages are locked in forever.”

This perspective aligns with Browne’s own view that the debate is often oversimplified. “The science shows the relationship between biology and performance is far more complex,” he said. “It’s not just about one hormone or one factor—it’s about how all these elements interact.”

A Call for Understanding

Despite the heightened rhetoric, Browne remains hopeful. He believes the core of the issue is the desire to play and compete, a fundamental right that transcends gender. “At the heart of all the intensity are a small number of athletes who just want to play the sports they love,” he said. For Browne, the journey from a closeted player to a trailblazer has been both challenging and transformative.

The paperback edition of *Let Us Play* is set for release on May 26, a testament to his commitment to sharing his story. Through his work, he aims to bridge the gap between personal experience and scientific understanding, offering a perspective that is both relatable and grounded in evidence. “This is not just about me,” he said. “It’s about everyone who has ever felt like they didn’t belong in the space they were meant to be.”

In the end, the debate over transgender athletes is not just about fairness—it’s about recognition. Browne’s journey, from the frozen rink to the pages of a book, underscores the importance of seeing beyond the surface. “We need to stop treating sport as a battleground for identity politics,” he said. “It should be a place where everyone, regardless of their gender, can thrive.”

A Critical Window to Stop Hantavirus Is Opening. Not All Countries Are Managing Exposed Travelers the Same Way

A critical window to stop hantavirus – The MV Hondius, a cruise ship infected with hantavirus, reached its final destination on Monday, marking the start of a crucial phase in the global response to the outbreak. Public health officials now face a significant challenge as they monitor passengers for potential secondary infections. This incident has become a pivotal moment for testing containment strategies, especially since the last major pandemic. The discovery of the Andes strain on the vessel—responsible for a 40% fatality rate—has sparked debates about how best to track and mitigate the virus’s spread among travelers.

The Global Containment Challenge

As the ship’s journey concluded, attention shifted to the health protocols for its passengers. The Andes strain, known for its high mortality rate, has raised concerns about how different nations will handle exposed individuals. While some countries have implemented strict measures, others rely on voluntary compliance, creating a patchwork of approaches. This divergence in strategies highlights the complexity of managing a disease that thrives in the silent incubation period.

“Countries are choosing different paths to curb the virus, and that creates uncertainty,” said Dr. Isaac Bogoch, a professor at the University of Toronto. “It’s not just about one nation’s actions anymore—it’s about coordination on a global scale.”

Bogoch, alongside Dr. Jason Andrews from Stanford University, recently analyzed past outbreaks to model the virus’s behavior. Their preprint study, which examines cases from 1996 and 2018 in Argentina, suggests that the average time between infection and symptom onset is about three weeks. However, the virus can manifest as early as five to 10 days before symptoms appear, underscoring the need for extended monitoring. This finding has implications for quarantine periods and testing protocols worldwide.

Timing the Danger Zone

The May 2 death of a German passenger aboard the MV Hondius serves as a key milestone. Researchers confirmed the cause of the infections on that day, revealing the Andes strain’s presence. For the remaining passengers, this date acts as a rough estimate for when the most contagious phase might conclude. While symptoms typically emerge within six weeks of exposure, the majority of countries are enforcing a 42-day observation period, beginning May 10, to ensure no cases are overlooked.

“Reliance on symptoms alone risks missing infections in the early stages,” Bogoch warned. “If you wait until someone shows signs, you’re already behind the curve.”

Public health authorities in various regions have adopted distinct methods to address the risk. Spain and France have mandated full quarantine for all passengers, requiring them to isolate for the duration of the 42-day window. In contrast, the United States and the United Kingdom have opted for a more flexible approach, encouraging travelers to voluntarily isolate while undergoing regular check-ins. These varying strategies reflect differing priorities in balancing public safety with individual freedoms.

Quarantine Variability and Public Anxiety

Travelers are now navigating a spectrum of quarantine conditions. Some are confined to hospitals, while others are monitored at home. This disparity has fueled confusion and fear, particularly among those worried about the virus’s proximity to their communities. The Public Health Agency of Canada recently confirmed that a passenger who had been isolated during the outbreak tested positive for the Andes strain, reinforcing the urgency of widespread vigilance.

Bogoch’s research emphasizes that testing should occur before symptoms appear to detect infections early. His team found that individuals can shed the virus days prior to showing signs, which complicates efforts to rely solely on symptomatic monitoring. “Without proactive testing, we may miss critical cases,” he explained. “This is especially important for preventing household transmission or community spread.”

Country-Specific Measures and Lessons from the Past

Historically, Argentina has managed Andes hantavirus outbreaks through systematic measures like regular testing and strict quarantines. These methods have proven effective in containing the disease within the country. However, the MV Hondius situation presents a new challenge: ensuring that international travelers comply with these protocols. Bogoch noted that the shift from localized control to global coordination introduces potential errors.

In the U.S., 18 passengers who returned last week are being given options for quarantine. They can isolate at home or choose the National Quarantine Center at the University of Nebraska Medical Center. This approach allows flexibility but also depends on individuals adhering to guidelines. Meanwhile, in Spain and France, passengers are required to stay in designated facilities for the full 42 days, offering more centralized oversight.

Other nations have taken mixed approaches. For example, some countries have implemented periodic testing for passengers, aiming to catch infections early. However, the U.S. has recommended waiting until symptoms emerge before conducting tests, a strategy that Bogoch argues may not be sufficient. “Testing only when symptoms appear could leave a window for the virus to spread unnoticed,” he said.

Implications for Public Health and Future Preparedness

The incident on the MV Hondius has reignited discussions about the importance of early detection. Without timely intervention, the virus can spread rapidly, especially in enclosed spaces like ships. The study by Bogoch and Andrews also highlights the role of antiviral drugs in treatment, even though none are specifically approved for the Andes strain. These medications are most effective when administered early, emphasizing the need for swift diagnosis.

As countries refine their strategies, the focus remains on minimizing risk while maintaining travel flow. The global health community is watching closely to see how these measures will hold up against the virus’s hidden nature. With the incubation period and symptoms appearing days after exposure, the 42-day monitoring window is a critical tool for identifying cases and preventing outbreaks in new regions.

The MV Hondius case is a test of how well nations can adapt their public health responses. While some have established robust protocols, others are still figuring out the best balance between precaution and practicality. As the first signs of the Andes strain’s spread in the U.S. emerge, the effectiveness of these measures will determine whether the virus can be contained or if it will ignite new waves of concern across the globe.

Buyer beware of sunscreens: New report finds few meet safety standards

Buyer beware of sunscreens – As summer approaches, consumers are advised to prepare their sunscreen supplies, yet a majority of available products fall short in delivering both reliable protection and safety. A recent report by the Environmental Working Group (EWG), a nonprofit organization focused on health and environmental advocacy, reveals that only a fraction of the sunscreens on store shelves meet rigorous safety criteria. This year’s analysis, marking the guide’s 20th anniversary, evaluated 2,784 products and identified just 550—roughly 20%—as effectively and safely shielding against harmful solar radiation.

EWG’s 2026 Sunscreen Guide Reveals a Disappointing 20% Safety Rate

The 2026 Guide to Sunscreens, published on May 19, highlights the need for careful selection among available options. It categorizes the top-performing products, including specialized formulations for infants, children, and adults engaged in outdoor activities. The report also features recommendations for daily-use sunscreens, such as moisturizers with SPF and lip balms with sun protection. To qualify for inclusion, sunscreens must offer comprehensive defense against both UVA and UVB rays, which are known to degrade skin health and contribute to DNA damage.

EWG excludes sprays and powders from its recommendations due to concerns about inhalation risks, particularly for individuals with respiratory conditions. While manufacturers often emphasize high SPF values—such as 50+ or 100+—the report challenges the perceived superiority of these claims. It notes that even less expensive sunscreens with SPF 50+ can provide comparable protection, blocking up to 98% of UVB rays, which is only marginally less than products with higher SPF ratings. This suggests that consumers may be overpaying for minimal improvements in effectiveness.

SPF Misleading: Fewer Differences Between High and Moderate Levels

Some sunscreens may exaggerate their SPF claims, according to a peer-reviewed study conducted by EWG scientists. The findings indicate that, on average, these products offer only 25% of the UVA protection and 59% of the UVB protection stated on packaging. This discrepancy raises questions about the transparency of labeling practices and the actual benefits consumers receive. The report underscores that SPF levels beyond 50+ do not significantly enhance protection, making it easier for brands to market higher numbers without substantial performance gains.

Retinyl Palmitate: A Concerning Ingredient in Decline

The guide also identifies retinyl palmitate, a derivative of vitamin A, as a potential risk. Although dermatologists recommend it for anti-aging benefits, it may interact negatively with sunlight. Friedman, a senior scientist at EWG, explained that in 2010, about 40% of sunscreens contained retinyl palmitate. Today, that figure has dropped to just 3%, a significant improvement for consumer safety. Despite this reduction, the ingredient remains in a small portion of products, warranting further scrutiny.

“Retinyl palmitate is part of the retinoid family that dermatologists recommend to fight wrinkles and other signs of aging. Those products come with warnings not to expose skin to the sun,” said Friedman. “In 2010, about 40% of products contained retinal palmitate,” Friedman said. “Today that’s dropped down to 3%, which is good news for consumers.”

Mineral-Based Sunscreens Lead the Way

Of the 550 recommended products, 497 are mineral-based, relying on zinc oxide and titanium dioxide to create a physical barrier against UV rays. Unlike chemical sunscreens, these formulations sit on the skin’s surface rather than penetrating deeper layers, reducing the likelihood of irritation or toxicity. While zinc oxide and titanium dioxide were once criticized for their white appearance, modern innovations have largely eliminated this drawback, making them more appealing to a wider audience.

Chemical sunscreens, by contrast, function by absorbing UV radiation through a series of reactions that convert it into heat. For decades, these ingredients were considered safe, but recent research has raised alarms. In 2019, FDA scientists discovered that six commonly used chemicals could enter the bloodstream at unsafe levels after just one day of application. These compounds remained in the blood for several days, with some, like homosalate and oxybenzone, persisting above safety thresholds for over two weeks.

Oxybenzone: A Controversial Chemical with Environmental Consequences

Oxybenzone, one of the most widely used chemicals in sunscreens, has been linked to endocrine disruption, a process that interferes with hormonal systems and can lead to developmental, reproductive, or neurological issues. Studies have shown that it is present in human breast milk, blood, and urine, with one investigation finding it in over 97% of US urine samples. This has prompted regulatory action, including bans in Hawaii, Key West, Florida, the US Virgin Islands, Thailand, and other regions concerned about its environmental impact.

Research highlights oxybenzone’s role in coral bleaching and reef degradation, as well as its potential to cause genetic harm in marine life. The 2026 guide notes that oxybenzone usage has declined from 70% of products in the early 2000s to just 5% today. However, even with this reduction, only 53 chemically based sunscreens are deemed safe, suggesting that some concerns remain.

While the guide acknowledges progress in reducing harmful ingredients, it emphasizes the importance of continued vigilance. Consumers are encouraged to prioritize mineral-based options or select chemical sunscreens that avoid known risks, such as oxybenzone. By doing so, they can balance effectiveness with safety, ensuring their skin remains protected without exposing it to potential long-term harm.